Related Experiment Video
Updated: May 16, 2026

12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Cellular prion protein: from physiology to pathology.
Sei-ichi Yusa1, José B Oliveira-Martins, Yoshiko Sugita-Konishi
1Division of Microbiology, National Institute of Health Sciences, Tokyo, Japan. s-yusa@nihs.go.jp
Viruses
|December 4, 2012
Summary
Prion protein (PrP(C)) processing by proteases is crucial for normal function and preventing neurotoxicity. Understanding these proteases is key to prion disease research.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- The human cellular prion protein (PrP(C)) is a membrane glycoprotein with known N-glycosylation sites.
- PrP(C) processing yields N-terminal (N1) and C-terminal (C1) fragments, similar to amyloid precursor protein (APP) in Alzheimer's disease.
- The proteases responsible for PrP(C) cleavage and their roles in prion biology are not fully understood.
Purpose of the Study:
- To review historical and recent evidence on the proteases involved in cellular prion protein (PrP(C)) proteolysis.
- To elucidate the physiological and pathological significance of PrP(C) processing.
- To highlight recent advancements in understanding PrP(C) proteolysis in prion diseases.
Main Methods:
- Western blot analysis of human brain homogenates.
- PNGase F treatment to remove N-glycosylations and reveal PrP(C) fragments (N1 and C1).
- Review of experimental evidence and recent studies on PrP(C) proteolysis.
Main Results:
- PNGase F treatment unexpectedly generated two dominant PrP(C) fragments (N1 and C1).
- A strong correlation exists between neurotoxicity and impaired PrP(C) proteolysis.
- Non-cleavable PrP(C) mutants induce neurotoxicity, even without infectious prions.
Conclusions:
- PrP(C) proteolysis is physiologically and pathologically important.
- Understanding PrP(C) processing is critical for comprehending prion biology and disease mechanisms.
- Recent research and mouse models are advancing knowledge of PrP(C)-cleaving proteases.
Related Concept Videos
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

